Zhao Han, He Yan, Ren Yue-Rong, Chen Bai-Hua
Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China.
Hunan Clinical Research Center of Ophthalmic Disease, Changsha 410011, Hunan Province, China.
Int J Ophthalmol. 2019 Dec 18;12(12):1939-1950. doi: 10.18240/ijo.2019.12.17. eCollection 2019.
The incidence of diabetes mellitus (DM) and its complications have increased considerably worldwide. Diabetic keratopathy is the major complication of the cornea characterized by delayed corneal wound healing, decreasing corneal epithelial sensitivity, and recurrent corneal ulcers. There is accumulating evidence that diabetic keratopathy is correlated with the hyperglycemic state. Different corneal components may produce different alterations under hyperglycemia. In addition, diabetic nerve alteration may become a novel biomarker of early-stage DM. Abnormalities of the corneal nerve plexus have been associated with diabetic inflammatory states. There is rapidly growing evidence based on investigations of diabetic corneal nerves through confocal microscopy. Understanding the molecular pathogenesis caused by hyperglycemia may assist in the identification of novel biomarkers, as well as therapeutic targets for early treatment. This review mainly summarizes recent findings on corneal alteration and pathogenesis in DM.
糖尿病及其并发症的发病率在全球范围内显著增加。糖尿病角膜病变是角膜的主要并发症,其特征为角膜伤口愈合延迟、角膜上皮敏感性降低以及复发性角膜溃疡。越来越多的证据表明,糖尿病角膜病变与高血糖状态相关。在高血糖情况下,角膜的不同成分可能会产生不同的改变。此外,糖尿病神经改变可能成为早期糖尿病的一种新型生物标志物。角膜神经丛异常与糖尿病炎症状态有关。基于共聚焦显微镜对糖尿病角膜神经的研究,相关证据迅速增加。了解高血糖引起的分子发病机制可能有助于识别新型生物标志物以及早期治疗的靶点。本综述主要总结了糖尿病患者角膜改变和发病机制的最新研究结果。